Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Thoracic Neoplasms × Echocardiography × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Cardiotoxicity 13 Breast Neoplasms 7 Lymphoma, Non-Hodgkin 4 Heart Failure 4 Neoplasms 3 Lymphoma 3 Prostatic Neoplasms 2 Multiple Myeloma 2 Lymphoma, B-Cell 2 Leukemia 2 Heart Diseases 2 Burkitt Lymphoma 2 Ventricular Dysfunction, Left 1 Ventricular Dysfunction 1 Thoracic Neoplasms 1 Small Cell Lung Carcinoma 1 Radiation Injuries 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Philadelphia Chromosome 1 Obesity 1 Neoplasm, Residual 1 Myeloproliferative Disorders 1 Myelodysplastic Syndromes 1 Metabolic Syndrome 1 Mesothelioma 1 Memory Disorders 1 Melanoma 1 Lymphoproliferative Disorders 1 Lymphomatoid Granulomatosis 1 Lymphoma, T-Cell, Peripheral 1

Interventions

Carboplatin 10 pembrolizumab 5 Pemetrexed 5 osimertinib 4 Paclitaxel 4 durvalumab 3 atezolizumab 3 Cisplatin 3 selpercatinib 2 pralsetinib 2 entinostat 2 apatinib 2 Radiosurgery 2 Injections 2 Erlotinib Hydrochloride 2 Bevacizumab 2 130-nm albumin-bound paclitaxel 2 toripalimab 1 taletrectinib 1 sotorasib 1 sintilimab 1 repotrectinib 1 pegylated granulocyte colony-stimulating factor 1 patritumab 1 napabucasin 1 ficlatuzumab 1 efineptakin alfa 1 cobimetinib 1 ceralasertib 1 cemiplimab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03396614 2024-02-28

CROSS SECT

University Medical Center Groningen

Thoracic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡